The looming threat of bedaquiline resistance in tuberculosis

Eur Respir J. 2020 Jun 4;55(6):2000718. doi: 10.1183/13993003.00718-2020. Print 2020 Jun.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Diarylquinolines
  • Humans
  • Mycobacterium tuberculosis*
  • Tuberculosis* / drug therapy
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents
  • Diarylquinolines
  • bedaquiline